Quinazoline-2-carboxylic acid → HCID 71529078, compound
Reaction equation
[F:1][C:2]1[CH:3]=[C:4]([C@H:12]([NH:18][C:19]([C:21]2[CH:30]=[C:29]3[C:24]([CH:25]=[N:26][C:27]([NH:31][CH:32]4CCOC[CH2:33]4)=[N:28]3)=[CH:23][CH:22]=2)=[O:20])[C@@H:13]2[CH2:17][CH2:16][CH2:15][NH:14]2)[CH:5]=[CH:6][C:7]=1C(F)(F)F.FC1C=C([C@@H](NC(C2C=C3C(C=NC(NC(C)C)=N3)=CC=2)=O)[C@@H]2CCCN2)C=CC=1[C:45]([F:48])([F:47])[F:46].FC1C=C([C@@H](NC(C2C=C3C(C=NC(NC4CCOCC4)=N3)=CC=2)=O)[C@@H]2CCCN2)C=CC=1C(F)(F)F.[Cl:109]C1C=C([C@H](NC(C2C=C3C(C=NC(NC4CCOCC4)=N3)=CC=2)=O)[C@@H]2CCNC2)C=CC=1F.ClC1C=C([C@@H](NC(C2C=C3C(C=NC(NC4CCOCC4)=N3)=CC=2)=O)[C@@H]2CCNC2)C=CC=1F.ClC1C=C([C@@H](NC(C2C=C3C(C=NC(NC4CCOCC4)=N3)=CC=2)=O)[C@H]2CCNC2)C=CC=1F.ClC1C=C([C@H](NC(C2C=C3C(C=NC(NC4CCOCC4)=N3)=CC=2)=O)[C@H]2CCNC2)C=CC=1F.ClC1C=CC([C@@H](NC(C2C=C3C(C=NC(NC4CCOCC4)=N3)=CC=2)=O)[C@@H]2CCCN2)=CC=1F.FC1C=C([C@@H](NC(C2C=C3C(C=NC(NC4CCOCC4)=N3)=CC=2)=O)[C@@H]2CCCN2)C=CC=1OC.FC1C=C([C@@H](NC(C2C=C3C(C=NC(N[C@@H](C4CC4)C)=N3)=CC=2)=O)[C@@H]2CCCN2)C=CC=1OC.FC1C=C([C@H](NC(C2C=C3C(C=NC(NC4CCOCC4)=N3)=CC=2)=O)[C@H]2C[C@H](F)CN2)C=CC=1OC.ClC1C=CC([C@H](NC(C2C=C3C(C=NC(NC4CCOCC4)=N3)=CC=2)=O)[C@H]2CC[C@@H](C)N2)=CC=1F.N1C2C(=CC=CC=2)C=NC=1C(O)=O>>[Cl:109][C:7]1[CH:6]=[CH:5][C:4]([C@H:12]([NH:18][C:19]([C:21]2[CH:30]=[C:29]3[C:24]([CH:25]=[N:26][C:27]([NH:31][C@@H:32]([CH3:33])[C:45]([F:48])([F:47])[F:46])=[N:28]3)=[CH:23][CH:22]=2)=[O:20])[C@@H:13]2[CH2:17][CH2:16][CH2:15][NH:14]2)=[CH:3][C:2]=1[F:1]Participants
Reactant 13
Product 1
Procedure
2-(Tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(3-fluoro-4-trifluoromethyl-phenyl)-(S)-pyrrolidin-2-yl-methyl]-amide (I-3), 2-isopropylamino-quinazoline-7-carboxylic acid [(S)-(3-fluoro-4-trifluoromethyl-phenyl)-(R)-pyrrolidin-2-yl-methyl]-amide (I5) 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(3-fluoro-4-trifluoromethyl-phenyl)-(R)-pyrrolidin-2-yl-methyl]-amide (I-7), 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(R)-(3-chloro-4-fluoro-phenyl)-(R)-pyrrolidin-3-yl-methyl]-amide (I-8), 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(R)-(3-chloro-4-fluoro-phenyl)-(S)-pyrrolidin-3-yl-methyl]-amide (I-9), 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(3-chloro-4-fluoro-phenyl)-(S)-pyrrolidin-3-yl-methyl]-amide (I-10), 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(3-chloro-4-fluoro-phenyl)-(R)-pyrrolidin-3-yl-methyl]-amide (I-11), 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(4-chloro-3-fluoro-phenyl)-(R)-pyrrolidin-2-yl-methyl]-amide (I-23), 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(3-fluoro-4-methoxy-phenyl)-(R)-pyrrolidin-2-yl-methyl]-amide (I-24), 2-((R)-1-cyclopropyl-ethylamino)-quinazoline-7-carboxylic acid [(S)-(3-fluoro-4-methoxy-phenyl)-(R)-pyrrolidin-2-yl-methyl]-amide (I-26), 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(3-fluoro-4-methoxy-phenyl)-((2R,4S)-4-fluoro-pyrrolidin-2-yl)-methyl]-amide (I-31), 2-(tetrahydropyran-4-ylamino)-quinazoline-7-carboxylic acid [(S)-(4-chloro-3-fluoro-phenyl)-((2R,5R)-5-methyl-pyrrolidin-2-yl)-methyl]-amide (I-35) and 2-((S)-2,2,2-trifluoro-1-methyl-ethylamino)-quinazoline-7-carboxylic acid [(S)-(4-chloro-3-fluoro-phenyl)-(S)-pyrrolidin-2-yl-methyl]-amide (I-40) were prepared analogously from the appropriate 2-substitued quinazoline-2-carboxylic acid and the requisite amine.
Sources & evidence
- ORD record
- ord-120e3d7f399440b09f0b0d90384e9cba
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09187462B2
Reaction notes
Loading…